Advertisement
Advertisement

MAZE

MAZE logo

Maze Therapeutics, Inc. Common Stock

43.58
USD
Sponsored
-1.42
-3.16%
Jan 30, 15:59 UTC -5
Closed
exchange

After-Market

43.58

0.00
0.00%

MAZE Earnings Reports

Positive Surprise Ratio

MAZE beat 2 of 4 last estimates.

50%

Next Report

Date of Next Report
--
Estimate for Q-- -- (Revenue/ EPS)
--
/
--
Implied change from Q3 25 (Revenue/ EPS)
--
/
--
Implied change from Q-- -- (Revenue/ EPS)
--
/
--

Maze Therapeutics, Inc. Common Stock earnings per share and revenue

On Nov 06, 2025, MAZE reported earnings of -0.66 USD per share (EPS) for Q3 25, beating the estimate of -0.72 USD, resulting in a 8.68% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -3.48% price change (close before vs. close after earnings).
Looking ahead to -- --, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Regeneron Pharmaceuticals Inc
Report Date
Jan 30, 2026 For Q4 25
Estimate
$10.84
Actual
$11.44
Surprise
+5.52%
logo
Nurix Therapeutics, Inc. Common stock
Report Date
Jan 28, 2026 For Q4 25
Estimate
-$0.88
Actual
-$0.82
Surprise
+7.66%
FAQ
For Q3 2025, Maze Therapeutics, Inc. Common Stock reported EPS of -$0.66, beating estimates by 8.68%, and revenue of $0.00, 0% as expectations.
The stock price moved down -3.48%, changed from $29.63 before the earnings release to $28.60 the day after.
The next earning report is scheduled for --.
Based on -- analysts, Maze Therapeutics, Inc. Common Stock is expected to report EPS of -- and revenue of -- for Q-- --.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement